SCHEMBL10148024

SCHEMBL10148024

CC(C)(Sc1ccc(F)cc1)C(=O)NNC(=O)c1cc(C(C)(C)C)on1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.52
MAPK1 P28482 1/20 0.52
SMN1; SMN2 Q16637 6/20 0.46
MAPK14 Q16539 1/20 0.46
GAA P10253 2/20 0.43
GFER P55789 1/20 0.43
NPC1 O15118 4/20 0.41
RAB9A P51151 4/20 0.41
PKM P14618 1/20 0.38
TSHR P16473 1/20 0.38
HTT P42858 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
SCD O00767 1/20 0.37
SCD5 Q86SK9 1/20 0.37
THRB P10828 1/20 0.36
POLB P06746 1/20 0.36
RAPGEF3 O95398 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10148017 0.81 CNR2 (0.36) ALDH1A1MAPK1SMN1; SMN2MAPK14GAA
SCHEMBL352560 0.79 CNR2 (0.56) ALDH1A1MAPK1SMN1; SMN2MAPK14GAA
SCHEMBL13618735 0.78 ALDH1A1 (0.51) ALDH1A1MAPK1SMN1; SMN2MAPK14GAA
SCHEMBL13393043 0.71 MAPK14 (0.48) ALDH1A1SMN1; SMN2MAPK14NPC1RAB9A
SCHEMBL12095580 0.70 RAB9A (0.52) SMN1; SMN2MAPK14NPC1RAB9APKM
SCHEMBL10147498 0.68 ALDH1A1 (0.42) ALDH1A1MAPK1SMN1; SMN2NPC1RAB9A
SCHEMBL26795644 0.68 ALDH1A1 (0.57) ALDH1A1MAPK1SMN1; SMN2MAPK14NPC1
SCHEMBL11134573 0.66 ALDH1A1 (0.60) ALDH1A1MAPK1SMN1; SMN2MAPK14NPC1
SCHEMBL18407332 0.66 ALDH1A1 (0.56) ALDH1A1MAPK1SMN1; SMN2MAPK14NPC1
SCHEMBL12824585 0.64 SLC22A12 (0.51) ALDH1A1HTTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2418207-A1 Sulfone compounds which modulate the CB2 receptor Boehringer Ingelheim International GmbH (DE) 2012-02-15 EP disclosed